Adaptimmune Therapeutics Plc ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $2.05 on 03/08/24 and the lowest value was $0.42 on 11/28/23.
52-week price history of ADAP Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Adaptimmune Therapeutics Plc ADR’s current trading price is -24.88% away from its 52-week high, while its distance from the 52-week low is 266.67%. The stock’s price range during this period has spanned from $0.42 to $2.05. In the Healthcare sector, the Adaptimmune Therapeutics Plc ADR’s shares surpassed a trading volume of approximately 2.09 million for the day, which was noticeably higher compared to the average daily volume of 9.1.79 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly rise of 170.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 349.84M and boasts a workforce of 449 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8231, with a change in price of +0.8750. Similarly, Adaptimmune Therapeutics Plc ADR recorded 1,271,252 in trading volume during the last 100 days, posting a change of +131.58%.
Examining ADAP’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ADAP stands at 0.64. Similarly, the long-term debt-to-equity ratio is also 0.50.
ADAP Stock Stochastic Average
Today, Adaptimmune Therapeutics Plc ADR’s raw stochastic average for the past 50 days stands at 64.34%, indicating a rise from the raw stochastic average of the last 20 days, which was 43.33%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 64.98% and 73.15% respectively.
ADAP Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 94.20%.However, over the last six months, we can see a weaker performance of 109.44%. Over the last 30 days, the price of ADAP has fallen by 33.91%. And in the last five days, it has surged by 4.05%.
